tiprankstipranks
Trending News
More News >
Parkway Life Real Estate Investment Trust (SG:C2PU)
:C2PU
Advertisement

Parkway Life Real Estate Investment (C2PU) AI Stock Analysis

Compare
44 Followers

Top Page

SG:C2PU

Parkway Life Real Estate Investment

(OTC:C2PU)

Rating:69Neutral
Price Target:
S$4.50
▲(11.11%Upside)
The overall stock score of 69 reflects a strong financial performance with healthy profitability and cash flow management. However, weak technical indicators and a relatively high P/E ratio suggest caution. The dividend yield provides a buffer, but market momentum remains a concern.
Positive Factors
Earnings Visibility
Highly visible and stable earnings are underpinned by a strong foothold in the Singapore private hospital market.
Strategic Expansion
The acquisition of 11 nursing homes in France represents a strategic entry into a third core market, providing an NPI yield of 6.5%.
Negative Factors
Currency Risk
Currency risks are present as PLife REIT derives approximately 40% of its earnings from healthcare assets in Japan and is exposed to foreign exchange volatility.
Finance Costs
Finance costs have increased 14.9% due to funding of capex for Project Renaissance and new acquisitions as well as higher interest costs from SGD-denominated debts.

Parkway Life Real Estate Investment (C2PU) vs. iShares MSCI Singapore ETF (EWS)

Parkway Life Real Estate Investment Business Overview & Revenue Model

Company DescriptionParkway Life Real Estate Investment Trust (C2PU) is one of Asia's largest listed healthcare real estate investment trusts. It invests primarily in income-producing real estate and real estate-related assets in the Asia-Pacific region, focusing on the healthcare and healthcare-related industry. Its portfolio includes hospitals, nursing homes, and other healthcare facilities, providing a stable and growing income stream for its investors.
How the Company Makes MoneyParkway Life Real Estate Investment Trust generates revenue primarily through the rental income obtained from its portfolio of healthcare-related properties. These properties are leased to healthcare operators and service providers under long-term lease agreements, ensuring a steady flow of rental income. Additionally, the trust may periodically engage in property acquisitions and divestments to optimize its portfolio and maximize returns. Significant partnerships with established healthcare operators enhance the trust's ability to maintain high occupancy rates and secure favorable lease terms, contributing to its financial performance.

Parkway Life Real Estate Investment Financial Statement Overview

Summary
Parkway Life Real Estate Investment exhibits a solid financial position characterized by strong profitability and effective cash flow management. While revenue growth has faced recent challenges, the company maintains healthy margins and a balanced leverage strategy, positioning it well within the REIT - Healthcare Facilities industry.
Income Statement
84
Very Positive
The company demonstrates strong profitability with a consistent gross profit margin. However, while the net profit margin is healthy, recent revenue growth is slightly negative, indicating potential challenges in maintaining top-line growth. EBIT margin is unavailable, but EBITDA margin remains robust, reflecting efficient operations.
Balance Sheet
75
Positive
The balance sheet presents a stable equity ratio, indicating a solid equity position relative to total assets. The debt-to-equity ratio is moderate, reflecting a balanced approach to leverage. Return on equity is strong, suggesting effective use of equity to generate profits.
Cash Flow
78
Positive
Operating cash flow remains strong, supporting net income well. However, free cash flow growth has been inconsistent, with a decline in the most recent year. The free cash flow to net income ratio is solid, indicating good cash conversion from earnings.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue153.49M147.47M129.97M120.70M120.89M
Gross Profit126.74M124.59M121.87M111.23M112.53M
EBITDA113.88M121.20M112.14M344.92M101.73M
Net Income95.04M100.47M41.14M331.88M87.22M
Balance Sheet
Total Assets2.55B2.33B2.34B2.35B2.07B
Cash, Cash Equivalents and Short-Term Investments29.47M28.50M40.01M25.79M22.66M
Total Debt886.11M828.47M851.89M828.01M793.65M
Total Liabilities981.20M919.58M931.66M910.43M883.36M
Stockholders Equity1.57B1.41B1.41B1.43B1.18B
Cash Flow
Free Cash Flow46.68M77.65M30.74M78.17M85.73M
Operating Cash Flow95.79M108.69M94.63M89.86M90.31M
Investing Cash Flow-239.93M-49.56M-125.18M-74.99M-28.57M
Financing Cash Flow147.35M-67.92M47.75M-9.98M-61.46M

Parkway Life Real Estate Investment Technical Analysis

Technical Analysis Sentiment
Positive
Last Price4.05
Price Trends
50DMA
4.06
Negative
100DMA
4.09
Negative
200DMA
3.93
Positive
Market Momentum
MACD
-0.01
Positive
RSI
48.89
Neutral
STOCH
42.26
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:C2PU, the sentiment is Positive. The current price of 4.05 is below the 20-day moving average (MA) of 4.06, below the 50-day MA of 4.06, and above the 200-day MA of 3.93, indicating a neutral trend. The MACD of -0.01 indicates Positive momentum. The RSI at 48.89 is Neutral, neither overbought nor oversold. The STOCH value of 42.26 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SG:C2PU.

Parkway Life Real Estate Investment Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
69
Neutral
S$2.64B26.116.39%3.68%-0.99%-6.50%
68
Neutral
$3.73B14.182.80%4.74%19.82%
65
Neutral
$2.04B17.222.45%5.04%0.60%-0.30%
65
Neutral
$3.50B30.23-0.32%5.25%0.01%-110.22%
60
Neutral
S$1.71B8.06-2.15%6.65%-11.65%-137.98%
54
Neutral
S$2.12B-6.38%3.26%-4.01%-66.90%
* Real Estate Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SG:C2PU
Parkway Life Real Estate Investment
4.05
0.57
16.45%
SG:TS0U
OUE Commercial Real Estate Investment Trust
0.30
0.04
15.38%
SG:9A4U
ESR-REIT
2.64
0.10
4.06%
SG:T82U
Suntec Real Estate Investment
1.19
0.07
6.44%
SG:TQ5
Frasers Property
0.97
0.20
25.98%

Parkway Life Real Estate Investment Corporate Events

Parkway Life REIT Holds Annual General Meeting to Discuss Performance and Strategies
May 19, 2025

Parkway Life REIT held its Annual General Meeting on April 21, 2025, with key figures from the company and its partners in attendance. The meeting was led by Mr. Ho Kian Guan, the Independent Director and Chairman of the Board. The event served as a platform for the management to engage with unitholders and discuss the company’s performance and future strategies. This meeting is crucial for maintaining transparency and trust with stakeholders, ensuring that they are informed about the company’s operations and strategic direction.

The most recent analyst rating on (SG:C2PU) stock is a Hold with a S$4.00 price target. To see the full list of analyst forecasts on Parkway Life Real Estate Investment stock, see the SG:C2PU Stock Forecast page.

PLife REIT Issues New Units to Manager for Fee Payment
May 16, 2025

Parkway Life Real Estate Investment Trust (PLife REIT) has announced the issuance of 31,865 new units to its manager, Parkway Trust Management Limited (PTM), as part payment for management fees for the first quarter of 2025. The units were issued at an average price of S$3.93 per unit, determined by the volume weighted average price on the SGX-ST. This issuance increases the total units in PLife REIT to 652,420,408, with PTM holding 1,396,208 units. The move reflects PLife REIT’s ongoing strategy to manage its financial obligations through equity, potentially impacting its financial structure and stakeholder interests.

The most recent analyst rating on (SG:C2PU) stock is a Hold with a S$4.00 price target. To see the full list of analyst forecasts on Parkway Life Real Estate Investment stock, see the SG:C2PU Stock Forecast page.

Parkway Life REIT Announces Change in Company Secretary
Apr 30, 2025

Parkway Life Real Estate Investment Trust has announced a change in its company secretary, with Ms. Chan Wan Mei resigning and Ms. Joannah P. Resol being appointed as her successor, effective April 30, 2025. This change reflects the company’s ongoing adjustments in its management team, which could have implications for its operational continuity and stakeholder relations.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 25, 2025